Segments |
Segments The Company’s segment reporting structure consists of two reportable segments and a Corporate category as follows: The Company’s Food Care and Product Care segments are considered reportable segments under FASB ASC Topic 280. Our reportable segments are aligned with similar groups of products. Corporate includes certain costs that are not allocated to or monitored by the reportable segments' management. The Company evaluates performance of the reportable segments based on the results of each segment. The performance metric used by the Company's chief operating decision maker to evaluate performance of our reportable segments is Adjusted EBITDA. The Company allocates expense to each segment based on various factors including direct usage of resources, allocation of headcount, allocation of software licenses or, in cases where costs are not clearly delineated, costs may be allocated on portion of either net trade sales or an expense factor such as cost of goods sold. We allocate and disclose depreciation and amortization expense to our segments, although depreciation and amortization are not included in the segment performance metric Adjusted EBITDA. We also allocate and disclose restructuring charges and impairment of goodwill and other intangible assets by segment, although they are not included in the segment performance metric Adjusted EBITDA since restructuring charges and impairment of goodwill and other intangible assets are categorized as Special Items. The accounting policies of the reportable segments and Corporate are the same as those applied to the Condensed Consolidated Financial Statements. The following tables show Net Sales and Adjusted EBITDA by reportable segment: | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | (In millions) | | 2019 | | 2018 | | 2019 | | 2018 | Net Sales: | | |
| | |
| | |
| | |
| Food Care | | $ | 729.6 |
| | $ | 727.2 |
| | $ | 2,120.6 |
| | $ | 2,136.5 |
| As a % of Total Company net sales | | 59.9 | % | | 61.3 | % | | 60.7 | % | | 61.5 | % | Product Care | | 488.9 |
| | 459.0 |
| | 1,371.6 |
| | 1,335.9 |
| As a % of Total Company net sales | | 40.1 | % | | 38.7 | % | | 39.3 | % | | 38.5 | % | Total Company Net Sales | | $ | 1,218.5 |
| | $ | 1,186.2 |
| | $ | 3,492.2 |
| | $ | 3,472.4 |
| | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | (In millions) | | 2019 | | 2018 | | 2019 | | 2018 | Adjusted EBITDA from continuing operations | | |
| | |
| | |
| | |
| Food Care | | $ | 159.6 |
| | $ | 145.4 |
| | $ | 458.1 |
| | $ | 415.5 |
| Adjusted EBITDA Margin | | 21.9 | % | | 20.0 | % | | 21.6 | % | | 19.4 | % | Product Care | | 84.0 |
| | 76.4 |
| | 243.0 |
| | 233.3 |
| Adjusted EBITDA Margin | | 17.2 | % | | 16.6 | % | | 17.7 | % | | 17.5 | % | Corporate | | (2.5 | ) | | (2.9 | ) | | (7.5 | ) | | (7.6 | ) | Total Company Adjusted EBITDA from continuing operations | | $ | 241.1 |
| | $ | 218.9 |
| | $ | 693.6 |
| | $ | 641.2 |
| Adjusted EBITDA Margin | | 19.8 | % | | 18.5 | % | | 19.9 | % | | 18.5 | % |
The following table shows a reconciliation of net earnings before income tax provision to Total Company Adjusted EBITDA from continuing operations: | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | (In millions) | | 2019 | | 2018 | | 2019 | | 2018 | Earnings before income tax provision | | $ | 102.3 |
| | $ | 109.0 |
| | $ | 234.8 |
| | $ | 339.3 |
| Interest expense, net | | 48.5 |
| | 44.8 |
| | 136.6 |
| | 131.3 |
| Depreciation and amortization, net of adjustments(1) | | 53.2 |
| | 41.0 |
| | 131.4 |
| | 121.9 |
| Special Items: | | | | | | | | | Restructuring charges(2) | | 6.9 |
| | 6.6 |
| | 43.6 |
| | 22.3 |
| Other restructuring associated costs(3) | | 12.8 |
| | 0.7 |
| | 50.8 |
| | 2.5 |
| Foreign currency exchange loss (gain) due to highly inflationary economies | | 1.3 |
| | (0.4 | ) | | 3.4 |
| | (0.4 | ) | Charges related to the Novipax settlement agreement | | — |
| | — |
| | 59.0 |
| | — |
| Charges related to acquisition and divestiture activity | | 6.0 |
| | 13.5 |
| | 9.2 |
| | 31.3 |
| Gain from class-action litigation settlement | | — |
| | — |
| | — |
| | (12.6 | ) | Other Special Items(4) | | 10.1 |
| | 3.7 |
| | 24.8 |
| | 5.6 |
| Pre-tax impact of Special Items | | 37.1 |
| | 24.1 |
| | 190.8 |
| | 48.7 |
| Total Company Adjusted EBITDA from continuing operations | | $ | 241.1 |
| | $ | 218.9 |
| | $ | 693.6 |
| | $ | 641.2 |
|
| | (1) | Depreciation and amortization by segment were as follows: |
| | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | (In millions) | | 2019 | | 2018 | | 2019 | | 2018 | Food Care | | $ | 30.6 |
| | $ | 25.6 |
| | $ | 81.8 |
| | $ | 79.8 |
| Product Care | | 22.7 |
| | 15.5 |
| | 50.7 |
| | 42.5 |
| Total Company depreciation and amortization(i) | | 53.3 |
| | 41.1 |
| | 132.5 |
| | 122.3 |
| Depreciation and amortization adjustments | | (0.1 | ) | | (0.1 | ) | | (1.1 | ) | | (0.4 | ) | Depreciation and amortization, net of adjustments | | $ | 53.2 |
| | $ | 41.0 |
| | $ | 131.4 |
| | $ | 121.9 |
|
| | (i) | Includes share-based incentive compensation of $12.0 million and $25.2 million for the three and nine months ended September 30, 2019, respectively, and $8.3 million and $23.6 million for the three and nine months ended September 30, 2018, respectively. |
| | (ii) | Depreciation and amortization adjustments represent depreciation and amortization which is considered to be related to a Special Item and are also included in the Special Items presented in the above table. |
| | (2) | Restructuring charges by segment were as follows: |
| | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | (In millions) | | 2019 | | 2018 | | 2019 | | 2018 | Food Care | | $ | 3.9 |
| | $ | 2.3 |
| | $ | 26.3 |
| | $ | 8.4 |
| Product Care | | 3.0 |
| | 4.3 |
| | 17.3 |
| | 13.9 |
| Total Company restructuring charges | | $ | 6.9 |
| | $ | 6.6 |
| | $ | 43.6 |
| | $ | 22.3 |
|
| | (3) | Other restructuring associated costs for three and nine months ended September 30, 2019, primarily relate to fees paid to third-party consultants in support of Reinvent SEE and costs related to property consolidations resulting from Reinvent SEE. |
| | (4) | Other Special Items for the three and nine months ended September 30, 2019, primarily included fees related to professional services, mainly legal fees, directly associated with Special Items or events that are considered one-time or infrequent in nature. |
Assets by Reportable Segments The following table shows assets allocated by reportable segment. Assets allocated by reportable segment include: trade receivables, net; inventory, net; property and equipment, net; goodwill; intangible assets, net; and leased systems, net. | | | | | | | | | | (In millions) | | September 30, 2019 | | December 31, 2018 | Assets allocated to segments:(1) | | |
| | |
| Food Care | | $ | 1,941.6 |
| | $ | 1,914.4 |
| Product Care | | 2,723.8 |
| | 2,273.8 |
| Total segments | | 4,665.4 |
| | 4,188.2 |
| Assets not allocated: | | | | | Cash and cash equivalents | | $ | 200.0 |
| | $ | 271.7 |
| Income tax receivables | | 43.1 |
| | 58.4 |
| Other receivables | | 79.6 |
| | 81.3 |
| Deferred taxes | | 175.8 |
| | 170.5 |
| Other | | 512.5 |
| | 280.1 |
| Total | | $ | 5,676.4 |
| | $ | 5,050.2 |
|
| | (1) | Beginning in 2018, the Company implemented a change in allocation of Corporate expenses, which are now allocated to Food Care and Product Care segments. At that time, the Company revised the method of allocation for some assets including property and equipment, net and goodwill, which were previously unallocated. |
The assets allocated to segments as of December 31, 2018 have been revised to correct an error in the previous allocation of property and equipment, net starting in the first quarter 2018. Assets allocated to Food Care were understated by $372.9 million with an offset to Product Care of $369.6 million and $3.3 million to assets not allocated. There is no impact to consolidated assets at December 31, 2018. This error did not impact the Company's annual assessment of goodwill impairment or any other impairment considerations of long-lived assets.
|